New drug LIFE-001 put to the test in healthy volunteers
NCT ID NCT06904807
First seen Jan 10, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This early-stage study checks if LIFE-001 is safe for people. About 150 healthy adults aged 18 to 65 will receive the drug and be monitored for side effects and how the drug moves through their body. The goal is to gather basic safety information before testing it in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Veritus Research Pty Ltd
RECRUITINGBayswater, Victoria, 3163, Australia
Contact
Conditions
Explore the condition pages connected to this study.